BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27742808)

  • 1. How robust are clinical trials in heart failure?
    Docherty KF; Campbell RT; Jhund PS; Petrie MC; McMurray JJV
    Eur Heart J; 2017 Feb; 38(5):338-345. PubMed ID: 27742808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index.
    Gaudino M; Hameed I; Biondi-Zoccai G; Tam DY; Gerry S; Rahouma M; Khan FM; Angiolillo DJ; Benedetto U; Taggart DP; Girardi LN; Crea F; Ruel M; Fremes SE
    Circ Cardiovasc Qual Outcomes; 2019 Dec; 12(12):e006017. PubMed ID: 31822120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
    Huang X; Chen B; Thabane L; Adachi JD; Li G
    Osteoporos Int; 2021 Sep; 32(9):1713-1723. PubMed ID: 33595680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragility of Results in Ophthalmology Randomized Controlled Trials: A Systematic Review.
    Shen C; Shamsudeen I; Farrokhyar F; Sabri K
    Ophthalmology; 2018 May; 125(5):642-648. PubMed ID: 29241744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fragility of statistically significant findings from randomized trials in head and neck surgery.
    Noel CW; McMullen C; Yao C; Monteiro E; Goldstein DP; Eskander A; de Almeida JR
    Laryngoscope; 2018 Sep; 128(9):2094-2100. PubMed ID: 29683494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey.
    Evaniew N; Files C; Smith C; Bhandari M; Ghert M; Walsh M; Devereaux PJ; Guyatt G
    Spine J; 2015 Oct; 15(10):2188-97. PubMed ID: 26072464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care.
    Tignanelli CJ; Napolitano LM
    JAMA Surg; 2019 Jan; 154(1):74-79. PubMed ID: 30422256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fragility index in randomized clinical trials supporting clinical practice guidelines for acute coronary syndrome: measuring robustness from a different perspective.
    Gonzalez-Del-Hoyo M; Mas-Llado C; Blaya-Peña L; Siquier-Padilla J; Peral V; Rossello X
    Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):386-390. PubMed ID: 36882068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragility Index in Randomized Controlled Trials of Ischemic Stroke.
    Sato K; Toda T; Iwata A
    J Stroke Cerebrovasc Dis; 2019 May; 28(5):1290-1294. PubMed ID: 30765294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review.
    Campbell RT; Willox GP; Jhund PS; Hawkins NM; Huang F; Petrie MC; McMurray JJ
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27162229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragility Analysis of Statistically Significant Outcomes of Randomized Control Trials in Spine Surgery: A Systematic Review.
    Muthu S; Ramakrishnan E
    Spine (Phila Pa 1976); 2021 Feb; 46(3):198-208. PubMed ID: 32756285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragility Index in Cardiovascular Randomized Controlled Trials.
    Khan MS; Ochani RK; Shaikh A; Usman MS; Yamani N; Khan SU; Murad MH; Mandrola J; Doukky R; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2019 Dec; 12(12):e005755. PubMed ID: 31822121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the robustness of positive vascular surgery randomized controlled trials using their fragility index.
    Javidan A; Benipal H; Vi L; Li A; Lee Y; Feridooni T; Alaichi J; Naji F
    J Vasc Surg; 2024 Jan; 79(1):148-158.e3. PubMed ID: 37315910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragility of randomized clinical trials of treatment of clavicular fractures.
    Ruzbarsky JJ; Khormaee S; Rauck RC; Warren RF
    J Shoulder Elbow Surg; 2019 Mar; 28(3):415-422. PubMed ID: 30771826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fragility of findings of randomized controlled trials in shoulder and elbow surgery.
    Ruzbarsky JJ; Rauck RC; Manzi J; Khormaee S; Jivanelli B; Warren RF
    J Shoulder Elbow Surg; 2019 Dec; 28(12):2409-2417. PubMed ID: 31420227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fragility Index of Randomized Controlled Trials for Preterm Neonates.
    Li H; Liang Z; Meng Q; Huang X
    Front Pediatr; 2022; 10():876366. PubMed ID: 35615631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours.
    Desnoyers A; Wilson BE; Nadler MB; Amir E
    Cancer Treat Rev; 2021 Mar; 94():102167. PubMed ID: 33652263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic systolic heart failure].
    Hasenfuse G; Anker SD
    Dtsch Med Wochenschr; 2013 Aug; 138(31-32):1556. PubMed ID: 23884736
    [No Abstract]   [Full Text] [Related]  

  • 19. The fragility of statistically significant results from clinical nutrition randomized controlled trials.
    Pędziwiatr M; Mizera M; Wysocki M; Małczak P; Stefura T; Gajewska N; Torbicz G; Droś J; Kacprzyk A; Major P; Kłęk S; Bała M
    Clin Nutr; 2020 Apr; 39(4):1284-1291. PubMed ID: 31221372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any difference between angiotensin converting enzyme inhibitors and angiotensin receptor blockers for heart failure?
    Rain C; Rada G
    Medwave; 2015 Jul; 15 Suppl 1():e6177. PubMed ID: 26247213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.